Achilles Therapeutics

+$0.11 (+4.56%) Today
-$0.02 (-0.79%) As of 9:20 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACHL and other ETFs, options, and stocks.

About ACHL

Achilles Therapeutics Plc is a biopharmaceutical company engages in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens.

CEO
Iraj Ali
Employees
252
Headquarters
London, Greater London
Founded
2020

ACHL Key Statistics

Market cap
102.70M
Price-Earnings ratio
—
Dividend yield
—
Average volume
54.26K
High today
$2.52
Low today
$2.43
Open price
$2.43
Volume
63.96K
52 Week high
$14.09
52 Week low
$1.84

ACHL Earnings

-$8.38
-$5.59
-$2.79
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.50 per share
Actual
-$0.45 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure